AMPA Receptor

AMPA receptor antagonists and modulators act on glutamate-gated ion channels that carry fast excitatory transmission. The name comes from the selective agonist alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA). Each receptor is a tetramer of glutamate receptor subunits 1 to 4 (GluA1 to GluA4), first cloned in 1989. Alternative splicing gives flip and flop forms of each subunit, which differ in desensitization. NBQX and DNQX are competitive quinoxalinedione antagonists that also block kainate receptors. GYKI-52466 dihydrochloride is a noncompetitive antagonist of the 2,3-benzodiazepine class. Positive modulators include cyclothiazide, which reduces desensitization, aniracetam and the ampakine Ampalex.

Items 101-125 of 127

  • Leptin (116-130)
    Cat. No.
    A67340

    Leptin (116-130)

    Leptin (116-130) is a bioactive fragment of the leptin protein, known to activate AMPA receptors. This compound enhances AMPA receptor trafficking to synapses, facilitating activity-dependent synaptic plasticity in the hippocampus. Furthermore, Leptin (116-130) exhibits protective effects against synaptic disruption and neuronal cell death in amyloid toxicity models, making it valuable for research into Alzheimer's disease mechanisms.

    Out of stock

    All 3 sizes
  • LY-300168
    Cat. No.
    A67341

    LY-300168

    Synonyms: GYKI 53655

    LY-300168 is a non-competitive antagonist of the AMPA receptor, capable of crossing the blood-brain barrier. This compound has demonstrated the ability to attenuate hippocampal injury and mitigate sound-induced clonic and tonic convulsions. Its pharmacological properties make it a valuable tool for research into neurological disorders and the modulation of excitatory neurotransmission.

    Out of stock

    All 3 sizes
  • 5-Iodowillardiine
    Cat. No.
    A67344

    5-Iodowillardiine

    5-Iodowillardiine is a potent and selective agonist of the kainate receptor, specifically targeting receptors composed of hGluR5 subunits. This compound exhibits significant biological activity, making it a valuable tool in neuropharmacological research and studies investigating synaptic transmission and excitatory neurotransmission pathways. Its effectiveness in modulating kainate receptor activity makes it suitable for exploring the role of these receptors in various neurological conditions.

    1 mg
    $75.00
    5 mg
    $190.00
    All 6 sizes
  • AMPA-IN-1
    Cat. No.
    A67348

    AMPA-IN-1

    AMPA-IN-1 is a potent inhibitor of the AMPA receptor, which is critical for fast excitatory synaptic transmission and synaptic plasticity in the brain. By modulating AMPA receptor activity, AMPA-IN-1 demonstrates potential for research into various central nervous system disorders, including epilepsy. This compound may provide valuable insights into therapeutic strategies targeting excitatory neurotransmission.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • AMPA receptor modulator-6
    Cat. No.
    A67349

    AMPA receptor modulator-6

    AMPA receptor modulator-6 is a positive allosteric modulator (PAM) of the AMPA receptor, enhancing its activity and facilitating synaptic transmission. This compound is instrumental for studying neurological diseases and disorders, making it valuable for research into cognitive function, excitotoxicity, and synaptic plasticity. Its ability to modulate AMPA receptor activity offers insight into potential therapeutic strategies for conditions like Alzheimer's disease and multiple sclerosis.

    1 mg
    $155.00
    5 mg
    $395.00
    All 6 sizes
  • UBP301
    Cat. No.
    A67353

    UBP301

    UBP301 is a selective antagonist of kainate receptors, exhibiting an IC50 of 164 μM and a KD of 5.94 μM. With approximately 30-fold selectivity for kainate receptors over AMPA receptors, UBP301 can serve as a valuable tool in investigating synaptic transmission and neuropharmacology. This compound is useful for studies aimed at elucidating the roles of kainate receptors in various neurobiological processes and potential therapeutic applications in neurological disorders.

    1 mg
    $60.00
    5 mg
    $220.00
    All 3 sizes
  • Caroverine
    Cat. No.
    A67358

    Caroverine

    Caroverine is a competitive and reversible antagonist of NMDA and AMPA glutamate receptors. It also possesses antioxidant properties and acts as a calcium-blocking agent, demonstrating vasorelaxant effects. This compound is primarily utilized in research applications related to inner ear tinnitus.

    25 mg
    $1,655.00
    50 mg
    $2,115.00
    All 3 sizes
  • (S)-CPW 399
    Cat. No.
    A67367

    (S)-CPW 399

    (S)-CPW 399 is a subtype-selective full agonist of AMPA receptors, demonstrating a 20-fold higher affinity for GluA1 and GluA2 subunits compared to GluA3 and GluA4 subunits. By activating AMPA receptors with GluA1 subunits, (S)-CPW 399 significantly enhances the spontaneous firing rate of locus coeruleus noradrenergic neurons. This compound is valuable for research into neurological diseases, providing insights into synaptic transmission and neuronal excitability.

    Out of stock

    All 3 sizes
  • AMPA receptor antagonist-1
    Cat. No.
    A67369

    AMPA receptor antagonist-1

    AMPA receptor antagonist-1 is a selective antagonist of the AMPA receptor, functioning to inhibit excitatory neurotransmission in the central nervous system. This compound demonstrates potential therapeutic activity in the study of various neurological disorders, such as epilepsy and neurodegenerative diseases. Its application facilitates the exploration of AMPA receptor modulation and its role in synaptic plasticity and neuronal signaling.

    Out of stock

    All 3 sizes
  • AMPA-IN-2
    Cat. No.
    A67372

    AMPA-IN-2

    AMPA-IN-2 is a potent orally active inhibitor of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors, efficiently crossing the blood-brain barrier. This compound demonstrates significant anti-epileptic effects by reducing neuronal excitability and attenuating glutamatergic transmission. AMPA-IN-2 is effective in the pentylenetetrazol model of epilepsy, making it a promising candidate for research in the field of epilepsy and related neuronal excitability disorders.

    Out of stock

    All 3 sizes
  • SPD-502 sodium
    Cat. No.
    A67378

    SPD-502 sodium

    Synonyms: NS-1209 sodium

    SPD-502 sodium is a selective antagonist of the AMPA receptor, primarily targeting the iGluR for neuroprotective effects. This compound exhibits a high affinity (IC50 = 0.043 μM) and competitively inhibits AMPA-induced activity in rat cortical membranes and cultured mouse cortical neurons. In vivo studies demonstrate that SPD-502 sodium blocks AMPA-evoked spike activity in the hippocampus, effectively increasing seizure threshold in mice and offering significant protection against ischemia-induced neuronal damage in gerbils. These properties suggest that SPD-502 sodium is valuable for researching neurodegenerative diseases linked to glutamate excitotoxicity.

    25 mg
    $725.00
    All 1 sizes
  • GYKI-47261 dihydrochloride
    Cat. No.
    A67384

    GYKI-47261 dihydrochloride

    GYKI-47261 dihydrochloride is a selective, orally active antagonist of the AMPA receptor, exhibiting an IC50 of 2.5 μM. This compound demonstrates a wide range of anticonvulsive activity and offers neuroprotective effects, making it valuable for neurological research. Additionally, GYKI-47261 serves as a potent inducer of the cytochrome P450 enzyme CYP2E1, further expanding its potential applications in pharmacological studies.

    1 mg
    $235.00
    5 mg
    $590.00
    All 4 sizes
  • (R,S)-3,4-Dicarboxyphenylglycine
    Cat. No.
    A67387

    (R,S)-3,4-Dicarboxyphenylglycine

    Synonyms: (R,S)-3,4-DCPG

    (R,S)-3,4-Dicarboxyphenylglycine is an AMPA receptor antagonist that inhibits AMPA-mediated depolarization in motor neurons. This compound is useful for investigating the role of AMPA receptors in various neurological diseases. Its application in research allows for a better understanding of synaptic transmission and excitotoxicity in neurobiology.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • GYKI-47261
    Cat. No.
    A67388

    GYKI-47261

    GYKI-47261 is a selective, competitive antagonist of the AMPA receptor, exhibiting an IC50 of 2.5 μM. This compound demonstrates significant anticonvulsive activity and provides neuroprotective effects, making it valuable in neurological research. Additionally, GYKI-47261 is a potent inducer of CYP2E1, highlighting its potential implications in drug metabolism studies.

    Out of stock

    All 3 sizes
  • (R)-3,4-DCPG
    Cat. No.
    A67389

    (R)-3,4-DCPG

    (R)-3,4-DCPG is a selective antagonist of AMPA and NMDA receptors, demonstrating a Kd of 77 μM for AMPA. At a concentration of 500 μM, it fully antagonizes NMDA-induced depolarization, while exhibiting weaker antagonistic effects on kainate-induced depolarizations. This compound is valuable for research exploring synaptic transmission and neuropharmacology, particularly in studies investigating excitotoxicity and related neurological disorders.

    Out of stock

    All 3 sizes
  • AMPA receptor modulator-4
    Cat. No.
    A67391

    AMPA receptor modulator-4

    AMPA Receptor Modulator-4 is an orally active positive allosteric modulator targeting AMPA receptors (AMPAR PAM). This compound, a 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide, effectively crosses the blood-brain barrier. Research indicates that AMPA Receptor Modulator-4 enhances cognitive function and improves working memory performance in murine models, making it a valuable tool for studies on cognitive enhancement and neurological disorders.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • SPD-502
    Cat. No.
    A67392

    SPD-502

    Synonyms: NS-1209

    SPD-502 is a selective antagonist of the AMPA receptor, primarily targeting iGluR to inhibit glutamate-mediated excitatory signaling. It demonstrates a high binding affinity (IC50 = 0.043 μM) and effectively antagonizes AMPA-induced responses in rat cortical membranes and cultured mouse cortical neurons. In vivo studies reveal that SPD-502 significantly elevates the seizure threshold in mice and protects hippocampal neurons from ischemic damage in gerbils. These properties make SPD-502 a valuable reagent for exploring neuroprotective strategies in neurodegenerative diseases linked to glutamate excitotoxicity.

    Out of stock

    All 3 sizes
  • JAMI1001A
    Cat. No.
    A67396

    JAMI1001A

    JAMI1001A is a positive allosteric modulator of the AMPA receptor, which plays a crucial role in synaptic transmission and plasticity. This compound effectively enhances receptor activation by modulating the deactivation and desensitization processes of both flip and flop isoforms. JAMI1001A is primarily utilized in neurological research to investigate synaptic function and potential therapeutic strategies for cognitive disorders.

    5 mg
    $795.00
    All 1 sizes
  • PF-04701475
    Cat. No.
    A67416

    PF-04701475

    PF-04701475 is a potent AMPA receptor potentiator with an EC50 of 123 nM. This compound enhances synaptic transmission mediated by AMPA receptors, making it valuable for investigating mechanisms underlying neurological disorders. PF-04701475 can aid in the exploration of potential therapeutic strategies for conditions such as depression and cognitive decline.

    Out of stock

    All 3 sizes
  • DL-Willardiine
    Cat. No.
    A67417

    DL-Willardiine

    DL-Willardiine is an AMPA receptor antagonist with an IC50 of 2 μM. It is employed in neuropharmacology research to investigate excitatory neurotransmission and its implications in various neurological disorders. This compound serves as a valuable tool in studying the mechanisms of synaptic transmission and the effects of glutamatergic signaling.

    1 mg
    $70.00
    2 mg
    $105.00
    All 8 sizes
  • Philanthotoxin 74 diTFA
    Cat. No.
    A67419

    Philanthotoxin 74 diTFA

    Synonyms: PhTx 74 diTFA

    Philanthotoxin 74 diTFA is a selective AMPA receptor antagonist, primarily targeting the GluR3 and GluR1 subunits with IC50 values of 263 nM and 296 nM, respectively. This compound is instrumental in studies focused on synaptic transmission and neuropharmacology, providing valuable insights into excitatory neurotransmission and potential therapeutic interventions for neurological disorders. Its specificity makes it a useful tool for researchers investigating the role of AMPA receptors in various biological contexts.

    25 mg
    $1,530.00
    50 mg
    $1,950.00
    All 3 sizes
  • UoS12258
    Cat. No.
    A67423

    UoS12258

    UoS12258 is a selective positive allosteric modulator of the AMPA receptor, enhancing AMPA receptor-mediated synaptic transmission. This compound demonstrates significant potential in improving cognitive performance in various rat models, particularly in scenarios involving scopolamine-induced impairment and water maze tasks in aged rats. UoS12258 serves as a valuable tool for research in cognitive enhancement and synaptic function.

    1 mg
    $40.00
    5 mg
    $90.00
    All 5 sizes
  • LY339434
    Cat. No.
    A67427

    LY339434

    LY339434 is a potent and selective agonist of the GluR5 receptor. Its activation plays a critical role in modulating neuronal excitability and may influence pathways related to neuroprotection and neurotoxicity. This compound is valuable for research investigating the mechanisms of excitatory neurotransmission and neuronal survival in various neurological disorders.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • LY-503430
    Cat. No.
    A67436

    LY-503430

    LY-503430 is an orally active positive allosteric modulator of the AMPA receptor. This compound enhances AMPA receptor activity, making it useful for investigating synaptic transmission and neuronal excitability. LY-503430 is particularly relevant in research focused on neurological disorders, including Parkinson's disease.

    25 mg
    $2,665.00
    50 mg
    $3,430.00
    All 3 sizes
  • Dasolampanel
    Cat. No.
    A67437

    Dasolampanel

    Dasolampanel is a kainate receptor antagonist that modulates neuronal excitability by inhibiting the activity of kainate receptors, thereby decreasing glutamate-mediated excitatory transmission. This compound is valuable for research into neurological conditions characterized by excessive neuronal activation, including excitability disorders and sleep disturbances. Its role in the regulation of synaptic transmission makes it a significant tool for studying the underlying mechanisms of various excitatory neurotransmission disorders.

    1 mg
    $610.00
    5 mg
    $1,305.00
    All 6 sizes

Items 101-125 of 127

Added to your cart

View Cart Checkout

    Loading...